Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
Prescription, Nonprescription and Orphan Drugs
Targeted Cancer Therapies
Targeted Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Kenneth L Kehl1, Stacy W Gray1, Benjamin Kim1
1The University of Texas MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute; Frontier Science & Technology Research Foundation; Harvard Medical School; Brigham and Women's Hospital, Boston, MA; University of California San Francisco, San Francisco; University of California Los Angeles, Los Angeles; RAND Corporation, Santa Monica, CA; Veterans Affairs (VA) Health Services Research & Development, Roudebush VA; and Indiana University School of Medicine, Indianapolis, IN.
Most oncologists experienced cancer drug shortages, with practice structure influencing availability. Veterans Affairs oncologists reported fewer shortages and less use of alternative treatments compared to other practice types.
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10:49Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
Published on: June 16, 2022
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: